Modern low-molecular-weight heparins in the prevention and treatment of venous thromboembolic complications in oncourologic patients
Oncourologic diseases are accompanied by a risk for subsequent venous thromboembolic complications, which are rated the most dangerous in terms of thrombogenic effect. The article presents a review of the clinical studies of efficacy and safety, and the experience in using of modern low-molecular-we...
Main Authors: | N. V. Vorobyev, S. V. Popov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2756 |
Similar Items
-
PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN TRAUMAS OF LOCOMOTOR SYSTEM
by: S. S. KOPENKIN
Published: (2016-12-01) -
VENOUS THROMBOEMBOLIC COMPLICATIONS IN OBSTETRICS AND GYNECOLOGY
by: G. F. Totchiev, et al.
Published: (2017-12-01) -
PATHOGENETIC APPROACHES AND WAYS OF PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN TRAUMA PATIENTS
by: L. Yu. Ivashchuk
Published: (2018-07-01) -
Prevention of venous thromboembolic complications in oncological surgery (review of the literature)
by: A. M. Karsanov, et al.
Published: (2020-05-01) -
Pathogenesis and prevention of thromboembolic complications associated with the use of assisted reproductive technologies
by: S. V. Akinshina, et al.
Published: (2014-12-01)